Plunkett Research Online: ITeos Therapeutics Inc

ITEOS THERAPEUTICS INC (ITOS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin.....


ITEOS THERAPEUTICS INC

Ticker: ITOS
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 339 217-0162
Fax:
Address: 139 Main Street
Cambridge, MA 2142 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Michel DetheuxCEO/Director/President
Matthew GallCFO/Chief Accounting Officer
See More
ITeos Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of immuno-oncology therapeutics for patients. Its product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoin.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture